Serdexmethylphenidate

丝右哌甲酯

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSerdexmethylphenidate
Drug Alias Nameprodrug of d-methylphenidate (d-MPH)KP-1077KP 484KP-1077HKP-1077N +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentral nervous system stimulantsAdrenergic receptors modulators
TargetsAdrenergic receptors
Therapy Area/IndicationsNarcolepsyIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZevra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZevra Therapeutics IncCommave Therapeutics SA
Inactive CompaniesN/A
Active IndicationsNarcolepsyIdiopathic Hypersomnia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A